Advertisement

Picture EBD Group BIO Europe 2016 BEU Cologne November 600x60px
All >

Deals > Germany

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Germany or involving German organisations.

Total search results: 7001 | Ordered by Date (descending)
next pagenext page 1 2 3 4 ... 69 70 71  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
ITM Isotopen Technologien München–OTHER: investment, 201603 equity investment €20m from Medtech-focused family office 2016-03-07
Biocom–Nasdaq OMX: press release distribution, 201603 collab existent integration of channel news in Eurobiotechnews.eu portal 2016-03-06
Biolink (NO)–Evonik: investment, 201603 acquisition €na of MedPalett AS by Evonik from Biolink Group 2016-03-03
Grünenthal–Axxam: drug discovery services, 201603– collab to discover small moleucule lead structures to treat pain + inflammation 2016-03-03
Pulsar Photonics–High-Tech Gründerfonds: investment, 201603 seed financing from HTGF 2016-03-02
Cycle GmbH–Hamburg (govt): investment, 201603 seed financing round incl HTGF + Innovationsstarter Hamburg + Tim Bode 2016-03-01
Cycle GmbH–High-Tech Gründerfonds: investment, 201603 seed financing round incl HTGF + Innovationsstarter Hamburg + Tim Bode 2016-03-01
Cycle GmbH–PERSON: investment, 201603 seed financing round incl HTGF + Innovationsstarter Hamburg + Tim Bode 2016-03-01
Cycle GmbH–SEVERAL: investment, 201603 seed financing round incl HTGF + Innovationsstarter Hamburg + Tim Bode 2016-03-01
Merck (DE)–EMBL: drug discovery, 201603–201902 collab research 3y with EMBL Heidelberg w focus on cancer metabolism 2016-03-01
Retina Implant–SEVERAL: investment, 201602 private equity funding round €26m from existing + new investors 2016-02-29
Blue Scientific–Accurion: laboratory instruments, 201602– distribution Nanofilm Technology + Halcyonics products in UK + Nordics by Blue Scientific 2016-02-25
Curetis–RBC Capital Markets: investor conference, 201602 supply service Curetis presents at RBC Capital Markets Healthcare Conference 2016-02-23
Ergomed–MC Services: public relations, 201602 service existent for Ergomed plc 2016-02-18
MorphoSys–MC Services: public relations, 201602 service existent for MorphoSys AG 2016-02-18
Newron–MC Services: public relations, 201602 service existent for Newron Pharmaceuticals 2016-02-18
Strüngmann Group–MC Services: public relations, 201602 service existent for AiCuris Anti-infective Cures GmbH 2016-02-18
Ipsen–3B Pharmaceuticals: radiopharmaceutical, 201602– license ww excl for radiopharmaceuticals in oncology 2016-02-17
Apogenix–Germany (govt): grant, 201602 BMBF grant €3m for developm of companion diagnostic w R-Biopharm for APG101 in glioblastoma 2016-02-16
Merck (DE)–Weizmann Institute: life sciences, 201602– collab 3y framework agreement research 2016-02-16
Novartis–Pfizer: biosimilar, 201602– Sandoz acquires rights to PF-06438179 (infliximab) in EEA which Pfizer had to divest after Hospira acquisition 2016-02-12
Affimed–Leerink: investor conference, 201602 supply service Affimed presents at Leerink Partners Global Healthcare Conference in NYC 2016-02-11
Hemovent–SEVERAL: investment, 201602 financing round Series A $6m led by MIG Verwaltungs AG 2016-02-10
Qiagen–10x Genomics: genomic technology, 201602– collab co-developm + co-marketing of NGS + single-cell biology + bioinformatics solutions 2016-02-09
Tollys–Riboxx: cancer drug, 201602– license ww excl to Apoxxim TLR3-ligand programme to Tollys 2016-02-04
Univ Rochester–Indivumed: tissue bank, 201602– collab 3y €na to establish UMRC-Indivumed tissue bank for cancer research 2016-02-04
Curetis–Degroof Petercam: investor conference, 201602 supply service Curetis presents at Degroof Petercam’s Healthcare Seminar 2016-02-03
Labiotech.eu–SEVERAL: investment, 201602 seed financing round €6-digit led by WestTech Ventures 2016-02-03
SmartDyeLivery–SEVERAL: investment, 201602 seed financing from bm|t + Sparkasse Jena-Saale-Holzland 2016-02-03
Evotec–Michael J Fox Foundation: grant, 201602 research grant for further developm of TargetaSN programme to treat Parkinson’s disease 2016-02-02
InflaRx–MC Services: public relations, 201601 service existent by MC Services AG 2016-01-28
Medigene–Univ Lausanne: TCR technology, 201601– collab €na service by UNIL using NTAmer technology of TCMetrix 2016-01-25
Merck (US)–Affimed: cancer immunotherapy, 201601– collab €na clinical research combining AFM13 w pembrolizumab in Hodgkin lymphoma 2016-01-25
SeNostic–SEVERAL: investment, 201601 seed financing round led by HTGF 2016-01-25
RA-MAP Consortium–Protagen: biomarker discovery, 201601– collab Protagen joins RA-MAP Consortium contributing SeroTag platform for RA biomarker search 2016-01-21
Synoste–Evonik: investment, 201601 financing round Series A single-digit €n from Evonik + HTGF + Finnvera + Lifeline Ventures + business angels 2016-01-21
Synoste–High-Tech Gründerfonds: investment, 201601 financing round Series A single-digit €m from Evonik + HTGF + Finnvera + Lifeline Ventures + angels 2016-01-21
Vasopharm–Hume Brophy: public relations, 201601 service existent by Hume Brophy 2016-01-21
Vasopharm–SEVERAL: investment, 201601 financing round €20m led by HeidelbergCapital + Entrepreneurs Fund + Fort Rock Capital 2016-01-21
City of Hope–Cevec: rec protein production technology, 201601– license €na to CAP GT technology to Beckman Research Institute 2016-01-20
PharmGenomics (DE)–SEVERAL: investment, 201601 financing round incl ISB + KfW + private investors 2016-01-20
Abviris–High-Tech Gründerfonds: investment, 201601 financing round mid six-digit € figure from HTGF + MBG Schleswig-Holstein 2016-01-19
Abviris–Schleswig-Holstein (govt): investment, 201601 financing round mid six-digit € figure from HTGF + MBG Schleswig-Holstein 2016-01-19
Abviris–SEVERAL: investment, 201601 financing round mid six-digit € figure from HTGF + MBG Schleswig-Holstein 2016-01-19
Affimed–Noble Financial Capital Markets: investor conference, 201601 supply service Affimed NV presents at NobleCon12 Annual Investor Conference 2016-01-19
Zespri–Metabolomic Discoveries: metabolomic services, 201601– supply service MS-based profiling of kiwi fruit using Flavour Profiler Technology 2016-01-18
Emerald Cleantech–Evonik: investment, 201601 existent investment in Emerald Cleantech Fund III by Evonik Venturing 2016-01-15
GRC SinoGreen–Evonik: investment, 201601 investment €na in GRC SinoGreen Fund III by Evonik Venturing 2016-01-15
Pangaea Ventures–Evonik: investment, 201601 existent investment in Pangaea Ventures Fund III by Evonik Venturing 2016-01-15
MorphoSys–JPMorgan Chase: investor conference, 201601 supply service MorphoSys presents at JP Morgan Healthcare Conference 2016 2016-01-14
Ayoxxa–Germany (govt): business development, 201601– supply service support in US with German Accelerator Life Sciences programme 2016-01-13
Pepperprint–Germany (govt): business development, 201601– supply service support in US with German Accelerator Life Sciences programme 2016-01-13
Personal MedSystems–Germany (govt): business development, 201601– supply service support in US with German Accelerator Life Sciences programme 2016-01-13
Sonormed–Germany (govt): business development, 201601– supply service support in US with German Accelerator Life Sciences programme 2016-01-13
Apogenix–JPMorgan Chase: investor conference, 201601 supply service Apogenix presents at JP Morgan Healthcare Conference 2016 2016-01-12
BioNTech–JPMorgan Chase: investor conference, 201601 supply service BioNTech presents at JP Morgan Healthcare Conference 2016 2016-01-12
CureVac–JPMorgan Chase: investor conference, 201601 supply service CureVac presents at JP Morgan Healthcare Conference 2016 2016-01-12
HRTBT Medical Solutions–DocCheck: investment, 201601 financing round high 6-figure € sum from HTGF + DockCheck Guano 2016-01-12
HRTBT Medical Solutions–High-Tech Gründerfonds: investment, 201601 financing round high 6-figure € sum from HTGF + DockCheck Guano 2016-01-12
HRTBT Medical Solutions–SEVERAL: investment, 201601 financing round high 6-figure € sum from HTGF + DockCheck Guano 2016-01-12
Array BioPharma–Qiagen: molecular companion diagnostics, 201601– collab master agreement developm + commercialisation of CDx for drugs 2016-01-11
Curetis–JPMorgan Chase: investor conference, 201601 supply service Curetis participates at JP Morgan Healthcare Conference 2016 2016-01-11
Medigene–JPMorgan Chase: investor conference, 201601 supply service Medigene participates at JP Morgan Healthcare Conference 2016 2016-01-11
Strüngmann Group–JPMorgan Chase: investor conference, 201601 supply service AiCuris attends JP Morgan Healthcare Conference 2016 2016-01-11
Merck (DE)–Biocartis: molecular companion diagnostics, 201601– collab developm liquid biopsy Idylla RAS test RUO for mCRC 2016-01-07
BRAIN–MIG Fonds: investment, 201601 existent shareholding of 20% by MIG 2016-01-05
BRAIN–Oddo: investment banking, 201601– supply service Oddo Seydler is lead manager for IPO of BRAIN at FSE 2016-01-05
BRAIN–Putsch (Recaro): investment, 201601 existent shareholding of 51% by MP Betiligungs GmbH 2016-01-05
BRAIN–SEVERAL: investment, 201601–201602 IPO €32.5m net €31.5m w 3.5m+108k shares at €9/share at Frankfurt Stock Exchange 2016-01-05
Famille Michaud Apiculteurs–Bruker Corp: NMR FoodScreener, 201601– supply use of Honey-Profiling module of NMR FoodScreener for QC of honey 2016-01-01
Roche–Max Planck: drug discovery services, 201601–20812 collab LDC will act as translational incubator for small molecule projects w academic partners 2016-01-01
Mologen–Bâloise: investment, 201512 existing investor Bâloise Holding holding estimated 6% in Mologen 2015-12-31
Mologen–Deutsche Balaton: investment, 201512 existing investor holding estimated 5% in Mologen 2015-12-31
Mologen–Global Derivative Trading: investment, 201512 existing investor Global Derivative Trading GmbH owns estimated 24% in Mologen 2015-12-31
Mologen–Salvator Vermögensverwaltungs GmbH: investment, 201512 existing investor holding estimated 5% in Mologen 2015-12-31
Mologen–Signal Iduna: investment, 201512 existing investor Deutscher Ring Krankenversicherung holding estimated 6% in Mologen 2015-12-31
Boehringer–Polyphor: drug discovery, 201512 collab existent to identify + optimise drug candidates using macrocycle platform 2015-12-22
CRISPR Therapeutics–Bayer: investment, 201512– acquisition of minority stake for $35m by BLSC in connection with joint venture collaboration 2015-12-21
Sinphar Pharmaceutical–Medigene: EndoTAG-1, 201512–2016 acquisition of all EndoTAG assets by SynCore Biotechnology 2015-12-17
Boehringer–Sanofi: investment, 201512– EXCLUSIVE NEGOTIATIONS for €6.7b acquisition of BI consumer healthcare business (ww excl China) by Sanofi 2015-12-15
Myelo Therapeutics–SEVERAL: investment, 201512 financing round Series B incl VC Fonds Technologie Berlin + ELSA + JSC Valenta + Vladimir Nebolsin 2015-12-15
Neovacs–ActeaVentures: business consulting, 201512 supply service business development advisor for Neovacs license deal w Chong Kun Dang 2015-12-15
Photonis–MasCom: electron multiplier, 201512– supply by MasCom of multipliers for ICP-MS + resale by Photonis USA 2015-12-15
Sanofi–Boehringer: investment, 201512– EXCLUSIVE NEGOTIATIONS for €11.4b acquisition of Merial animal health business by BI 2015-12-15
NovaPump–SEVERAL: investment, 201512 financing round with bm|t + Sparkasse Jena-Saale-Holzland 2015-12-14
Sanofi–MAB Discovery: therapeutic antibodies, 201512– collab €na developm MAbs against selected Sanofi targets 2015-12-14
Genetrix (ES)–SEVERAL: investment, 201512 rights offering + private placement of Sygnis AG €5.6m with 2.963m new shares €1.9/share 2015-12-10
Wilex–Hopp Group: investment, 201512 investment €1.712m w 930,560 new shares at €1.84/share dievini Hopp BioTech holding 2015-12-09
Wilex–SEVERAL: investment, 201512 investment €815k w 443,124 new shares at €1.84/share to existent shareholders 2015-12-09
Affimed–Oppenheimer: investor conference, 201512 supply service Affimed presents at Oppenheimer Annual Healthcare Conference in New York 2015-12-08
BASF–Evogene: herbicides, 201512–201811 collab 3y r+d novel herbicides using Evogene’s computational discovery approach 2015-12-08
Probiodrug–GBC: investor conference, 201511 supply service Probiodrug AG presents at MKK Münchner Kapitalmarkt Konferenz 2015 2015-12-08
Max Planck–Bruker Corp: mass spectrometry s/w, 201512 supply Prof Baldwin at MPI ICE Jena early user of MetaboScape s/w to mine complex plant genomics 2015-12-07
Lucigen–Genetrix (ES): genomic reagents, 201512– distribution of Sygnis TruePrime + SunScript RT products for clinical oncology research in US 2015-12-03
Shuwen Biotech–BioNTech: molecular diagnostics, 201512– collab clin developm + excl distribution rights for MammaTyper test in China 2015-12-03
Boehringer–Univ Texas: cancer drugs, 201512– collab discovery therapeutic concepts for pancreatic cancer w MD Anderson Cancer Center 2015-12-02
Jennewein Biotechnologie–EU (govt): credit, 201512– loan €10m with equity-type transaction under InnovFin scheme from EIB 2015-12-02
Mayflower Bioscience–Genetrix (ES): genomic reagents, 201512– distribution of Sygnis TruePrime + SunScript RT products in US 2015-12-02
Amcure–Germany (govt): grant, 201512 BMBF research grant €1.9m to advance lead candidate into clinic 2015-12-01
Amcure–MacDougall Biomedical Communications: public relations, 201512 service existent by MacDougall 2015-12-01
next pagenext page 1 2 3 4 ... 69 70 71  next pagenext page



Advertisement

Picture BIO Deutschland EBDC 2016 Frankfurt 600x60px

To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Mologen AG Investing in Power of Immunotherapy Middle 600x60px

» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Mologen AG Investing in Power of Immunotherapy Middle 120x180px Picture EuropaBio European Biotech Week 2016 September 120x180px Picture EBD Group BIO Europe 2016 BEU Cologne November 120x180px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px